GAL3ST1 Inhibitors

GAL3ST1 inhibitors encompass a class of chemicals that indirectly inhibit the enzymatic activity of GAL3ST1 by intervening in the sulfation process or substrate availability. GAL3ST1 is responsible for transferring a sulfate group from the universal sulfate donor 3'-phosphoadenosine-5'-phosphosulfate (PAPS) to the 3-position of galactose in galactosylceramide, creating cerebroside sulfate, an important component of myelin in the central nervous system. The sulfation process is critical for the function of various biomolecules, and its disruption can lead to altered cellular functions.

Chlorate and perchlorate are known to interfere with sulfate uptake by competing with sulfate for its transporter, which can lead to reduced availability of the sulfate ion that is necessary for GAL3ST1's sulfotransferase activity. Similarly, molybdate, an analog of sulfate, competes with sulfate ions, potentially reducing the efficacy of sulfation reactions. Sodium tungstate inhibits enzymes containing molybdenum, which are involved in the reduction of sulfate to sulfite, a step preceding the formation of PAPS, thus indirectly affecting GAL3ST1. Compounds known to affect sulfotransferase activity, such as pentachlorophenol and triclosan, can also serve as indirect inhibitors. Pentachlorophenol acts by depleting the PAPS levels, while triclosan is suggested to interact with the sulfotransferase enzyme, potentially altering its activity. Flavonoids like quercetin have been shown to inhibit sulfotransferase enzymes, which could extend to GAL3ST1. Endocrine disruptors, such as bisphenol A and phthalates like dibutyl phthalate, have been reported to inhibit sulfotransferase activities, which could, in turn, affect GAL3ST1.